Cargando…
Osteostatin Inhibits M-CSF+RANKL-Induced Human Osteoclast Differentiation by Modulating NFATc1
Parathyroid hormone-related protein (PTHrP) C-terminal peptides regulate the metabolism of bone cells. PHTrP [107–111] (osteostatin) promotes bone repair in animal models of bone defects and prevents bone erosion in inflammatory arthritis. In addition to its positive effects on osteoblasts, osteosta...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9369336/ https://www.ncbi.nlm.nih.gov/pubmed/35955685 http://dx.doi.org/10.3390/ijms23158551 |
_version_ | 1784766420752531456 |
---|---|
author | Ibáñez, Lidia Nácher-Juan, Josep Terencio, María Carmen Ferrándiz, María Luisa Alcaraz, María José |
author_facet | Ibáñez, Lidia Nácher-Juan, Josep Terencio, María Carmen Ferrándiz, María Luisa Alcaraz, María José |
author_sort | Ibáñez, Lidia |
collection | PubMed |
description | Parathyroid hormone-related protein (PTHrP) C-terminal peptides regulate the metabolism of bone cells. PHTrP [107–111] (osteostatin) promotes bone repair in animal models of bone defects and prevents bone erosion in inflammatory arthritis. In addition to its positive effects on osteoblasts, osteostatin may inhibit bone resorption. The aim of this study was to determine the effects of osteostatin on human osteoclast differentiation and function. We used macrophage colony-stimulating factor (M-CSF) and receptor activator of nuclear factor κB ligand (RANKL) to induce the osteoclast differentiation of adherent human peripheral blood mononuclear cells. Tartrate-resistant acid phosphatase (TRAP) staining was performed for the detection of the osteoclasts. The function of mature osteoclasts was assessed with a pit resorption assay. Gene expression was evaluated with qRT-PCR, and nuclear factor of activated T cells, cytoplasmic 1 (NFATc1) nuclear translocation was studied by immunofluorescence. We observed that osteostatin (100, 250 and 500 nM) decreased the differentiation of osteoclasts in a concentration-dependent manner, but it did not modify the resorptive ability of mature osteoclasts. In addition, osteostatin decreased the mRNA levels of cathepsin K, osteoclast associated Ig-like receptor (OSCAR) and NFATc1. The nuclear translocation of the master transcription factor in osteoclast differentiation NFATc1 was reduced by osteostatin. Our results suggest that the anti-resorptive effects of osteostatin may be dependent on the inhibition of osteoclastogenesis. This study has shown that osteostatin controls human osteoclast differentiation in vitro through the downregulation of NFATc1. |
format | Online Article Text |
id | pubmed-9369336 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-93693362022-08-12 Osteostatin Inhibits M-CSF+RANKL-Induced Human Osteoclast Differentiation by Modulating NFATc1 Ibáñez, Lidia Nácher-Juan, Josep Terencio, María Carmen Ferrándiz, María Luisa Alcaraz, María José Int J Mol Sci Article Parathyroid hormone-related protein (PTHrP) C-terminal peptides regulate the metabolism of bone cells. PHTrP [107–111] (osteostatin) promotes bone repair in animal models of bone defects and prevents bone erosion in inflammatory arthritis. In addition to its positive effects on osteoblasts, osteostatin may inhibit bone resorption. The aim of this study was to determine the effects of osteostatin on human osteoclast differentiation and function. We used macrophage colony-stimulating factor (M-CSF) and receptor activator of nuclear factor κB ligand (RANKL) to induce the osteoclast differentiation of adherent human peripheral blood mononuclear cells. Tartrate-resistant acid phosphatase (TRAP) staining was performed for the detection of the osteoclasts. The function of mature osteoclasts was assessed with a pit resorption assay. Gene expression was evaluated with qRT-PCR, and nuclear factor of activated T cells, cytoplasmic 1 (NFATc1) nuclear translocation was studied by immunofluorescence. We observed that osteostatin (100, 250 and 500 nM) decreased the differentiation of osteoclasts in a concentration-dependent manner, but it did not modify the resorptive ability of mature osteoclasts. In addition, osteostatin decreased the mRNA levels of cathepsin K, osteoclast associated Ig-like receptor (OSCAR) and NFATc1. The nuclear translocation of the master transcription factor in osteoclast differentiation NFATc1 was reduced by osteostatin. Our results suggest that the anti-resorptive effects of osteostatin may be dependent on the inhibition of osteoclastogenesis. This study has shown that osteostatin controls human osteoclast differentiation in vitro through the downregulation of NFATc1. MDPI 2022-08-01 /pmc/articles/PMC9369336/ /pubmed/35955685 http://dx.doi.org/10.3390/ijms23158551 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Ibáñez, Lidia Nácher-Juan, Josep Terencio, María Carmen Ferrándiz, María Luisa Alcaraz, María José Osteostatin Inhibits M-CSF+RANKL-Induced Human Osteoclast Differentiation by Modulating NFATc1 |
title | Osteostatin Inhibits M-CSF+RANKL-Induced Human Osteoclast Differentiation by Modulating NFATc1 |
title_full | Osteostatin Inhibits M-CSF+RANKL-Induced Human Osteoclast Differentiation by Modulating NFATc1 |
title_fullStr | Osteostatin Inhibits M-CSF+RANKL-Induced Human Osteoclast Differentiation by Modulating NFATc1 |
title_full_unstemmed | Osteostatin Inhibits M-CSF+RANKL-Induced Human Osteoclast Differentiation by Modulating NFATc1 |
title_short | Osteostatin Inhibits M-CSF+RANKL-Induced Human Osteoclast Differentiation by Modulating NFATc1 |
title_sort | osteostatin inhibits m-csf+rankl-induced human osteoclast differentiation by modulating nfatc1 |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9369336/ https://www.ncbi.nlm.nih.gov/pubmed/35955685 http://dx.doi.org/10.3390/ijms23158551 |
work_keys_str_mv | AT ibanezlidia osteostatininhibitsmcsfranklinducedhumanosteoclastdifferentiationbymodulatingnfatc1 AT nacherjuanjosep osteostatininhibitsmcsfranklinducedhumanosteoclastdifferentiationbymodulatingnfatc1 AT terenciomariacarmen osteostatininhibitsmcsfranklinducedhumanosteoclastdifferentiationbymodulatingnfatc1 AT ferrandizmarialuisa osteostatininhibitsmcsfranklinducedhumanosteoclastdifferentiationbymodulatingnfatc1 AT alcarazmariajose osteostatininhibitsmcsfranklinducedhumanosteoclastdifferentiationbymodulatingnfatc1 |